EDILIA GOMES: Open Payments
NPI 1992860571 · MELROSE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,442 in 35 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $712 · 2025 $1,442
Food & beverage: $1,304Education: $138
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $385 |
| Vanda Pharmaceuticals Inc. | 9 | $278 |
| Otsuka America Pharmaceutical, Inc. | 6 | $198 |
| Teva Pharmaceuticals USA, Inc. | 5 | $190 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Lundbeck LLC | 4 | $106 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $52 |
| ABBVIE INC. | 1 | $30 |
Products named: CAPLYTA, REXULTI, FANAPT, Auvelity, AUSTEDO XR, TRINTELLIX, VRAYLAR.
Industry payments across MA — which companies pay providers there.
